Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Prognostic Value of Structural and Functional Microvascular Dysfunction in Patients with Nonobstructive Coronary Artery Disease

Coronary microvascular dysfunction (CMD) is a paramount factor involved in the development of anginal syndromes. Among patients with angina and nonobstructive coronary artery disease with CMD, two patterns have been identified using minimal microvascular resistance: structural CMD, and functional CMD.

Valor pronóstico de disfunción microvascular estructural y funcional en pacientes con enfermedad coronaria no obstructiva

Structural CMD is characterized by decreased coronary flow reserve (CFR) in the presence of increased microvascular resistance. This subtype represents changes in the microvasculature such as arteriolar obliteration, which improves under conditions of maximal vasodilatation.

However, functional CMD is characterized by decreased CFR with normal or decreased microvascular resistance. This is related to increased myocardial oxygen demand or impaired coronary autoregulation. However, the prognostic relevance of these two CMD subtypes has not been evaluated.

The aim of this (multicenter, retrospective) ILIAS Registry was to evaluate the prognostic impact of structural vs. functional CMD in patients with nonobstructive coronary artery disease.

This study analyzed 1102 patients. Mean patient age was 63 years old, and 69% of subjects were male. The most analyzed artery was the anterior descending artery, followed by the circumflex artery. Patients were classified into four groups based on CFR (cutoff value <2.5), and two groups based on microvascular resistance: low and high (in terms of the microvascular resistance index [MRI] and the hyperemic microvascular resistance [HMR]).

Read also: Complicated Non-Stenotic Carotid Plaques: A Light in the Diagnosis of Cryptogenic Stroke?

Regarding the results, abnormal CFR values were associated with increased risk of MACE and treated vessel failure (TVF) at 5 years regardless of the values of microvascular resistance obtained. However, abnormal microvascular resistance values were not associated with increased MACE and TVF. Lastly, there were no differences between normal or abnormal microvascular resistance values in patients with normal CFR.

Conclusion

CMD, represented as a decrease in CFR, was associated with an increase in MACE and FVL at a 5-year follow-up. In contrast, microvascular resistance was not associated with adverse clinical events. In patients with CMD, there were no significant differences in MACE and TVF between structural CMD and functional CMD.

Dr. Andrés Rodríguez

Dr. Andrés Rodríguez.
Member o the Editorial Board of SOLACI.org.

Original Title: Prognostic value of structural and functional coronary microvascular dysfunction in patients with non-obstructive coronary artery disease; from the multicentre international ILIAS registry.

Reference: Coen K.M. Boerhout et al EuroIntervention 2022;18.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...